Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease
Authors:
- Fabrizio StocchiFSFabrizio Stocchi
- Laura VaccaLVLaura Vacca
- Stefano RuggieriSRStefano Ruggieri
- C. Warren OlanowCOC. Warren Olanow
- 1 June 2005
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 62 (6) , 905-910
Abstract
Research from JAMA Neurology — Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease — A Clinical and Pharmacokinetic StudyKeywords
This publication has 20 references indexed in Scilit:
- Levodopa in the treatment of Parkinson's disease: Current controversiesMovement Disorders, 2004
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's diseaseMovement Disorders, 1998
- De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmosetMovement Disorders, 1998
- Motor fluctuations during continuous levodopa infusions in patients with Parkinson's diseaseMovement Disorders, 1997
- What features improve the accuracy of clinical diagnosis in Parkinson's diseaseNeurology, 1992
- Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's diseaseMovement Disorders, 1992
- JEJUNAL DELIVERY OF LEVODOPA METHYL ESTERThe Lancet, 1989
- Long‐term duodenal infusion of levodopa for motor fluctuations in parkinsonismAnnals of Neurology, 1988
- Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observationsAnnals of Neurology, 1986